The tobramycin trough level test is employed to evaluate the toxicity of the drug. This broad-spectrum aminoglycoside is utilized for aerobic gram-negative bacteria resistant to less-toxic antibiotics, as well as for empirical treatment of Serratia and other microorganisms. Healthcare providers utilize this test to modify dosing intervals based on drug accumulation and toxicity, especially in advanced age and renal impairment.